Industry Focus

  • Mid-stage to late-stage private companies
  • Small-cap public companies
  • Life Sciences (e.g., pharmaceuticals, biotechnology, medical devices, biomedical technologies, neutraceuticals, agricultural biotechnology, and cosmeceuticals)

FACT: IN EUROPE, A MAJOR BLOCK TO GROWTH IS ACCESS TO ALIGNED INVESTORS

CONSCIOUS CAPITAL AG HELPS SCALE-UPS TO STAY IN EUROPE

We focus on companies that are raising amounts typically too large ( > CHF 30M ) for venture capital firms, angels, incubators, accelerators and crowdfunding portals.

We focus on companies that are raising amounts typically too small ( < CHF 50M ) for boutique investment banks and private equity firms.

Disclaimer:   Conscious Capital AG, Conscious Capital, Inc., and Conscious Giving, Inc. (collectively referred to hereinafter as “Conscious Capital”) are legally independent entities. Conscious Capital and its affiliates, and their respective employees, officers and directors take no part in the negotiation or execution of transactions for the purchase or sale of securities. Conscious Capital is not a registered broker-dealer in the United States and does not conduct any securities activities. This website is not to be used or considered as, does not constitute or form part of, an offer to or solicitation of an offer to sell, purchase, exchange or transfer any securities or invitation to subscribe for any securities in any jurisdiction, and does not constitute an advertisement of securities in any other jurisdiction. Use of this website is not for any person or entity that is a citizen or resident or located in any locality, state, country, or other jurisdiction in which such use would be contrary to law or regulation, or which would require any registration or licensing within such jurisdiction, including, but not limited to, the United States, Canada, Australia, the United Kingdom, or Japan. For additional disclaimers, please click here